Discovery of Potent and Selective Reversible Ubiquitin-Like Modifier Activating Enzyme 5 Inhibitors Targeting the UFMylation Pathway.
Mignone JJ, Jurica EA, Rajasekaran D, Robustelli J, McCarthy C, Quang PQ, Guo Q, Ball DJ, Donnell AF, Mahon BP, Mulligan D, Spronk SA, Srivastava S, Vik EC, Cavallaro CL, Chattergoon FJ, Ellsworth BA, Joshi S, Lees E, Lawrence RM, Li L, Mai S, Manik MK, Marsilio F, Mavrakis K, Murugan P, Newitt JA, Sheth P, Tredup J, Traeger SC, Weis DD, Yan C, Yanchunas J Jr, Zhang P, Wrobleski ST, Kalev P, Bronson JJ.
Mignone JJ, et al. Among authors: murugan p.
J Med Chem. 2025 Oct 9;68(19):20827-20845. doi: 10.1021/acs.jmedchem.5c02305. Epub 2025 Sep 25.
J Med Chem. 2025.
PMID: 40994290